IMSN Oxytocin Special Interest Group (OxytocinSIG)

The Oxytocin Special Interest Group is chaired by Rita K. Jew, President of ISMP.
Click on the titles to access the content

IMSN OxytocinSIG Charter


• IMSN Oxytocin Special Interest Group Charter Read on…

IMSN OxytocinSIG Members


• IMSN Oxytocin Special Interest Group Members List Read on…

April 20, 2022 OxytocinSIG meeting


• Agenda
• Minutes,
taken by Sunny Ro, ISMP International Medication Safety Management Fellow

May 19, 2022 OxytocinSIG meeting


• Agenda

• Minutes,
taken by Logan Moore, Medication-Use Safety and Policy Resident

• ISMP USA:
ISMP Oxytocin Medication Safety Best Practices – Logan Moore, Medication-Use Safety and Policy Resident Read on…

• ISMP Canada:
Oxytocin to Start or Advance Labour: 5 Questions to Ask – Alice Watt Read on…

June 30, 2022 OxytocinSIG meeting


• Agenda

• Minutes,
taken by Sunny Ro, ISMP International Medication Safety Management Fellow

• Uppsala Monitoring Centre (UMC)
Introducing #MedSafetyWeek - Federica Santoro, Communications Officer UMC and Ayako Fukushima, WHO Pharmacovigilance Team Read on…

• France
Oxytocin in France: a quite limited issue – Étienne Schmitt & Marie-France Gonzalvez, Prescrire, presented by Sunny Ro, ISMP International Medication Safety Management Fellow Read on…

August 19, 2022 OxytocinSIG meeting


• Agenda

• Minutes,
taken by Tyler Nichols, ISMP International Medication Safety Management Fellow

• KK Women’s & Children’s Hospital Singapour
Experience with Oxytocin - Mohammed Nazri (on behalf of Cynthia Leow), Principal Pharmacist, Medication Safety officer Read on…

• Saudi Medication Safety Center
Oxytocin reported errors – Saudi Arabia - Hind Almodaimegh, Associate Professor in Pharmacy Practice, King Saud Bin Abdulaziz University for Health Sciences Read on…